https://www.selleckchem.com/pr....oducts/Paclitaxel(Ta
NI, as LVI was associated with a higher overall-mortality in patients with LNI (HR1.66), than in patients without LNI (HR1.22). (all P less then 0.0001) CONCLUSIONS Our report highlights the detrimental impact of LVI on OS. Patients with LVI alone fared similarly to patients with LNI alone. Patients with both LVI and LNI had worse OS than those with only LVI or LNI, implying a synergetic detrimental interaction. Our findings demonstrate an important utility that LVI can provide in deciding patients' prognoses. The frequency of
Like
Comment
Share
